Literature DB >> 26183510

Possible autoimmune hepatitis induced after chronic active Epstein-Barr virus infection.

Yoshiko Wada1, Chikako Sato, Kyoko Tomita, Rika Ishii-Aso, Hiroaki Haga, Kazuo Okumoto, Yuko Nishise, Hisayoshi Watanabe, Takafumi Saito, Yoshiyuki Ueno.   

Abstract

Chronic active Epstein-Barr virus infection (CAEBV) can be manifested in a variety of systemic conditions, including interstitial pneumonia, malignant lymphoma, and coronary aneurysm. Sometimes it may be associated with hepatic failure, although the mechanism underlying CAEBV-related hepatotoxicity remains unclear. We encountered a case of autoimmune hepatitis (AIH) associated with CAEBV. A 61-year-old male was referred to our hospital because of abnormal liver enzyme levels after initial diagnosis of CAEBV had been made by laboratory tests and liver biopsy. On admission, positivity for anti-nuclear antibody was evident, and examination of the liver biopsy specimen showed findings compatible with AIH. Steroid administration was initiated, and the liver function parameters subsequently improved. Although phenotypic changes in liver biopsy specimens are rare in this condition, the present case could provide clues to the possible pathogenesis of AIH.

Entities:  

Mesh:

Year:  2013        PMID: 26183510     DOI: 10.1007/s12328-013-0438-2

Source DB:  PubMed          Journal:  Clin J Gastroenterol        ISSN: 1865-7265


  14 in total

Review 1.  Mechanisms for the induction of autoimmunity by infectious agents.

Authors:  K W Wucherpfennig
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

Review 2.  Autoimmune hepatitis.

Authors:  Edward L Krawitt
Journal:  N Engl J Med       Date:  2006-01-05       Impact factor: 91.245

3.  Clinical and virologic characteristics of chronic active Epstein-Barr virus infection.

Authors:  H Kimura; Y Hoshino; H Kanegane; I Tsuge; T Okamura; K Kawa; T Morishima
Journal:  Blood       Date:  2001-07-15       Impact factor: 22.113

4.  International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis.

Authors:  F Alvarez; P A Berg; F B Bianchi; L Bianchi; A K Burroughs; E L Cancado; R W Chapman; W G Cooksley; A J Czaja; V J Desmet; P T Donaldson; A L Eddleston; L Fainboim; J Heathcote; J C Homberg; J H Hoofnagle; S Kakumu; E L Krawitt; I R Mackay; R N MacSween; W C Maddrey; M P Manns; I G McFarlane; K H Meyer zum Büschenfelde; M Zeniya
Journal:  J Hepatol       Date:  1999-11       Impact factor: 25.083

Review 5.  Proposed guidelines for diagnosing chronic active Epstein-Barr virus infection.

Authors:  Motohiko Okano; Keisei Kawa; Hiroshi Kimura; Akihiro Yachie; Hiroshi Wakiguchi; Akihiko Maeda; Shosuke Imai; Shouichi Ohga; Hirokazu Kanegane; Shigeru Tsuchiya; Tomohiro Morio; Masaaki Mori; Shumpei Yokota; Shinsaku Imashuku
Journal:  Am J Hematol       Date:  2005-09       Impact factor: 10.047

6.  Identification of hepatitis A virus as a trigger for autoimmune chronic hepatitis type 1 in susceptible individuals.

Authors:  S Vento; T Garofano; G Di Perri; L Dolci; E Concia; D Bassetti
Journal:  Lancet       Date:  1991-05-18       Impact factor: 79.321

7.  Epstein-Barr virus as a trigger for autoimmune hepatitis in susceptible individuals.

Authors:  S Vento; L Guella; F Mirandola; F Cainelli; G Di Perri; M Solbiati; T Ferraro; E Concia
Journal:  Lancet       Date:  1995-09-02       Impact factor: 79.321

Review 8.  Severe chronic active Epstein-Barr virus infection syndrome.

Authors:  M Okano; S Matsumoto; T Osato; Y Sakiyama; G M Thiele; D T Purtilo
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.

Authors:  H Kimura; M Morita; Y Yabuta; K Kuzushima; K Kato; S Kojima; T Matsuyama; T Morishima
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Autoimmune hepatitis following hepatitis A virus infection.

Authors:  H I Huppertz; U Treichel; A M Gassel; R Jeschke; K H Meyer zum Büschenfelde
Journal:  J Hepatol       Date:  1995-08       Impact factor: 25.083

View more
  5 in total

1.  Autoimmune hepatitis following Epstein-Barr virus infection: a diagnostic dilemma.

Authors:  Haoran Peng; Tanna Lim; Jae Nam; Jin Lee
Journal:  BMJ Case Rep       Date:  2019-07-10

2.  False-positive serologies for acute hepatitis A and autoimmune hepatitis in a patient with acute Epstein-Barr virus infection.

Authors:  Marika Valota; Friedrich Thienemann; Benjamin Misselwitz
Journal:  BMJ Case Rep       Date:  2019-05-10

3.  Chronic Active Epstein-Barr Virus Infection Indistinguishable from Autoimmune Hepatitis: A Case Report.

Authors:  Suguru Ikeda; Takaaki Sugihara; Takuya Kihara; Yoshiki Hoshino; Yukako Matsuki; Takakazu Nagahara; Kenji Oyama; Jun-Ichi Okano; Satoshi Kuwamoto; Yasushi Horie; Hajime Isomoto
Journal:  Yonago Acta Med       Date:  2022-04-13       Impact factor: 1.371

Review 4.  Autoimmune hepatitis: current challenges and future prospects.

Authors:  Yoshio Aizawa; Atsushi Hokari
Journal:  Clin Exp Gastroenterol       Date:  2017-01-19

5.  [Autoimmune hepatitis following acute severe Epstein-Barr virus hepatitis].

Authors:  Khaoula El Montacer; Wafaa Hliwa; Fz El Rhaoussi; Mohammed Tahiri; Fouad Haddad; Ahmed Bellabah; Wafaa Badre
Journal:  Pan Afr Med J       Date:  2020-09-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.